San Raffaele
| Italien | Türkei | Polen | |
| infundierendes Knochentransplantat | von $2,500 | von $1,200 | von $1,800 |
Bookimed erhebt keine zusätzlichen Gebühren für infundierendes Knochentransplantat -Preise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihr infundierendes Knochentransplantat bei Ihrer Ankunft.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards für infundierendes Knochentransplantat einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu versorgen.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer infundierendes Knochentransplantat -Reise nie allein.
Tag 1
Tag 2
Tag 3
Tag 4
Tag 5-7
Woche 1-2
Woche 3-4
Woche 5-6
Woche 12
Bitte beachten Sie, dass der Genesungszeitplan jedes Patienten je nach individuellem Gesundheitszustand und Komplexität der Operation variieren kann.
Infuse bone graft risks include swelling, ectopic bone formation, and nerve irritation. In cervical procedures, severe throat swelling may obstruct airways. Other complications involve retrograde ejaculation and localized bone resorption. Specialists use recombinant human bone morphogenetic protein-2 (rhBMP-2) to stimulate natural bone growth.
Bookimed Expert Insight: While Infuse bone graft is common, Italian research hubs like San Raffaele prioritize rigorous patient screening. This hospital performs over 52,000 operations annually with IRCCS research accreditation. Data suggests that choosing centers with high surgical volumes reduces the likelihood of off-label complications. Always verify if your surgeon uses the FDA-approved collagen sponge delivery system.
Patient Consensus: Many patients report significant swelling that lasts weeks longer than traditional autografts. Most recommend confirming whether the use is on- or off-label to understand specific long-term risks.
Infuse Bone Graft and InductOs are identical products containing the active ingredient recombinant human bone morphogenetic protein-2 (rhBMP-2). Medtronic brands the product as Infuse in the United States, while it is marketed as InductOs throughout Italy and the European Union.
Bookimed Expert Insight: While technically identical, Italian clinics must adhere to stricter European Union dosing limits. Regional protocol restricts InductOs to 4.2mg per spinal level. This often leads to more standardized application techniques in Italian centers compared to varied U.S. practices. Major research hospitals like San Raffaele in Milan manage high volumes with 52,000 annual operations. They often maintain stricter adherence to these EMA-approved concentrations for patient safety.
Patient Consensus: Patients confirm InductOs provides solid fusion outcomes in Italy similar to Infuse results. Many suggest verifying if the product is included in public health coverage to manage expenses.
Infuse (Inductos) in Italy treats degenerative disc disease through single-level lumbar spine fusion and repairs acute tibia fractures. It contains dibotermin alfa to stimulate bone growth. Surgeons apply the solution to a collagen sponge for implantation during spinal or orthopedic procedures.
Bookimed Expert Insight: While Infuse is officially approved for anterior lumbar interbody fusion (ALIF), Italian private clinics like San Raffaele often see cases where it is requested for complex L5-S1 revisions. Patients should prioritize facilities with IRCCS accreditation. This certification signals the hospital integrates advanced research with active surgical care.
Patient Consensus: Patients often seek Infuse for ALIF to avoid the pain of harvesting their own donor bone. Many recommend asking surgeons specifically about AIFA labeling to understand potential off-label risks like swelling.
Infuse and Inductos (rhBMP-2) sales are currently restricted in Europe due to manufacturing quality concerns. The European Medicines Agency (EMA) suspended marketing authorizations following inspections that identified particle contamination risks. While direct patient danger was not found, sales remain halted until manufacturing sites meet regulatory standards.
Bookimed Expert Insight: Italian research centers like San Raffaele emphasize evidence-based alternatives for bone regeneration. While Inductos clinical availability is limited, high-volume centers often utilize advanced autograft techniques. These centers handle over 52,000 operations annually and prioritize IRCCS-validated protocols over restricted BMP-2 products.
Patient Consensus: Many patients find that Italian surgeons now prefer using a person's own bone. They report that access to Inductos is restricted to rare, case-by-case medical exceptions.
Italian hospitals utilize several biological and synthetic alternatives to Infuse (rhBMP-2), primarily focusing on autologous bone grafts and demineralized bone matrix. Top facilities like San Raffaele in Milan prioritize clinical research and utilize advanced biomimetic scaffolds like b.Bone and allogeneic tissues from certified regional tissue banks.
Bookimed Expert Insight: San Raffaele performs over 52,000 operations annually and holds IRCCS accreditation for research. This specific status allows their surgeons early access to domestic innovations like GreenBone. Patients can often access these cutting-edge biomimetic grafts which are standard there. These domestic alternatives provide performance similar to Infuse without the high import costs.
Patient Consensus: Many patients find that public hospital surgeons prefer iliac crest autografts for long-term stability. Some report initial drainage with demineralized bone matrix but confirm effective healing within 6 months.